期刊文献+

心脏再同步化治疗中经胸心外膜起搏导线的植入技术 被引量:3

The technique of epicardial lead implanted by thoracotomy in cardiac resynchronization therapy
下载PDF
导出
摘要 目的探讨经胸心外膜左心室导线植入在慢性充血性心力衰竭心脏再同步化治疗中的意义。方法对1例经静脉植入左心室导线因冠状静脉窦开口畸形而放弃的患者行经胸植入左心室心外膜导线植入。结果右心房、右心室心内膜起搏导线植入及两根心外膜起搏导线缝合均顺利,术后未出现严重并发症。术后2周后临床症状逐渐改善,NYHA心功能分级从术前Ⅲ、Ⅳ级提高至Ⅱ级,LVEDD从72mm减至66mm,优化程控起搏器后超声心动图描记术检查室间隔基底部与左心室侧壁间失同步性改善,第3天心外膜起搏导线阈值从术中的2.0V降为0.5V且稳定。已随访12周临床症状、心功能改善,组织多普勒显像示左心室内恢复同步化。结论心脏再同步化治疗经胸心外膜左心室导线植入是安全、可行的,特别是对经静脉途径失败的患者,是可选择的方法之一;术中左心室导线的定位及术后的综合处理十分重要。 Objective To explore clinical value of left ventricular (LV) epicardial lead implanted by thoracotomy in cardiac resynchronization therapy (CRT) of chronic congestive heart failure. Methods LV epicardial leads were implanted by thoracotomy in a patient after failed coronary sinus implantation for abnormal ostium of coronary sinus. Results Right atrial and ventricular endocardial leads and two LV epicardial leads were implanted successfully without any serious complication. Pacing threshold of the epicardial leads decreased from 2.0V during operation to 0.SV at third day post operation. Clinical symptoms improved gradually, NYHA functional class reduced from Ⅲ~Ⅳ to Ⅱ, LV diastolic diameter decreased from 72mm to 66mm, and dyssynchrony between interseptal base and LV lateral wall ameliorated under optimum pacing parameters two weeks later. Tissue Doppler image displayed resynchronization of LV contraction during 12 weeks follow-up. Conclusion LV epicardial lead implanted by thoracotomy is safe and feasible in CRT after failed transvenous approach. LV epicardial lead positioning during operation and rational management after operation is very important.
机构地区 浙江医院心内科
出处 《心电学杂志》 2007年第1期29-31,共3页 Journal of Electrocardiology(China)
关键词 心脏再同步化起搏 心外膜起搏导线 慢性充血性心力衰竭 植入 Cardiac resynchronization therapy, Epicardial pacing electrode, Chronic congestive heart failure, Implantation
  • 相关文献

参考文献9

  • 1Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med, 2002,346(24):1845.
  • 2Valls-Bertauh V, Mansourati J, Gilard M,et al. Adverse events with transvenous left ventricular pacing in patients with severe heart failure early experience from a single centre. Europace,2001,3(1):60.
  • 3Francesco D, Gianni G, Bruno D, et al. Hemodynamic effects of atrial septal pacing in cradiac resynchronization therapy patients.J Cardiovasc Electrophysiol, 2005,16(2):1.
  • 4Auricchio A, Klein H, Tockman B, et al. Transvenous biventricular pacing for heart failure: can the obstacles be overcome? Am J Cardiol, 1999,83(5B):136D.
  • 5Butter C, Auricchio A, Stellbrink C, et al. Should stimulation site be tailored in the individual heart failure patient? Am J Cardiol,2000,86(suppl):K 144.
  • 6Butter C, Auricchio A, Stellbrink C, et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation, 2001,104(25):3026.
  • 7Dekker L, Phelps,Dijkman, et al. Epicardial left ventricular lead placement for cardiac resynchronization therapy: Optimal pace site selection with pressure-volume loops .J Thorac Cardiovasc Surg,2004,127(6): 1641.
  • 8H Mair, J Sachweh, B Meurisc, et al. Surgical epicardial left ventricular lead versus coronary sinus lead placement in biventricular pacing. European J of Cardio-thoracic Surgery, 2005,27 (2):235.
  • 9Bert Hansky, SS EistrupJ Vogt, et al. Lead selection and implantation technique for biventricular pacing. Eur Heart J Supplements, 2004, 6 (Suppl D):D112.

同被引文献24

  • 1仲京,刘旸,解士胜,顾汉卿.人工机械心脏瓣膜的发展与展望[J].透析与人工器官,2006,17(1):22-26. 被引量:12
  • 2McMurray J J, Adamopoulos S, Anker S D et al. ESC guide- lines for the diagnosis and treatment of acute and chronic heartfailure 2012[J]. Eur J Heart Fail,2012,14(8) :803-69.
  • 3Tomczak C R, Paterson I, Haykowsky M J, et al. Cardiac re- synchronization therapy modulation of exercise left ventricular function and pulmonary Oz uptake in heart failure[J]. Am J Physiol Heart Circ Physiol,2012,302(12):H2635-H2645.
  • 4Haddad H,Mielniczuk L,Davies R A. Recent advances in the management of chronic heart failure[J]. Curt Opin Cardiol, 2012,27(2) : 161-168.
  • 5Turschner O, Ritscher G, Simon H. Criteria for patient selec- tion in cardiac resynchronization therapy[J]. Future Cardiol, 2010, 6(6): 871-880.
  • 6Doguet F, Honor6 C, Godin B, et al. Isolation of the phrenic nerve to suppress diaphragmatic contraction induced by cardiac resynchronization[J]. J Cardiovasc Electrophysiol, 2012, 23 (7) :778-780.
  • 7Papiashvilli M, Haitov Z, Fuchs T, et al. Left ventricular epi- cardial lead implantation for resynchronisation therapy using a video-assisted thoracoscopic approach[J]. Heart Lung Circ, 2011,20(4) : 220-222.
  • 8Gurevitz O, Nof E,Carasso S, et al. Programmable multiple pa- cing configurations help to overcome high left ventricular pa- cing thresholds and avoid phrenic nerve stimulation[J]. Pacing Clin Electrophysiol, 2005,28(12) : 1255-1259.
  • 9Biffi M, Boriani G. Phrenic stimulation management in CRT patients:are we there yet? [J]. Curr Opin Cardiol, 2011,26 (1) :12-16.
  • 10Champagne J, Healey J S,Krahn A D,et al. The effect of elec- tronic repositioning on left ventricular pacing and phrenic nerve stimulation[J].Europace, 2011,13 (3) : 409-415.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部